PCR Topics pp 130-135 | Cite as

Detection of EBNA2-mRNA in Primary Central Nervous System Lymphomas in Patients with AIDS

  • Arndt Rolfs
  • Hermann Christian Schumacher
  • Martin Preuß
  • Ines Weber
  • Barbara Trampenau
  • Klaus Weigel
  • Theo Dissmann


Epstein-Barr virus (EBV) is commonly associated with two different tumours — the Burkitt-lymphoma (BL), in which it has been primarily isolated and the nasopharyngeal carcinoma (NPC), an undifferentiated carcinoma. In both kinds of tumours association has been demonstrated by serological data and the identification of viral structures (DNA or antigen) within malignant cells. EBV infections are mostly asymptomatic and B lymphocytes are the target cells for the virus. In the phase of latency there is one infected cell in relation to 105 to 107 non-infected cells [1]. The importance of the immune system for the control of an EBV infection will be apparent in the scope of connated immunodeficiencies in which uncontrolled polyclonal proliferation of EBV-immortalized lymphoid cells is induced. Human- Immunodeficiency-Virus Type I (HIV-I) infected individuals take an elevated risk for the development of malignant lymphoma, mainly highly malignant non-Hodgkin-lymphoma. Obviously there is a significantly higher incidence (about 2% in HIV-I-infected subjects [2]) of primary intracerebral non-Hodgkin-lymphomas (PINHL). The yearly incidence of Aquired immunodeciency syndrome (AIDS)-associated PINHL has surpassed the incidence from all other causes for CNS tumors and could become as frequent als low-grade astrocytomas until 1991.


Primary Central Nervous System Lymphoma Brain Biopsy Stereotactic Brain Biopsy Burkitt Lymphoma Cell Line Human Lymphoid Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rocchi G, de Felici A, Ragona G et al. Quantitative evaluation of Epstein-Barr virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. New Engl J Med. 296, 132–134 (1977)PubMedCrossRefGoogle Scholar
  2. 2.
    Rosenblum ML, Levy RM, Bredesen DE et al. Primary Central Nervous System Lymphomas in Patients with AIDS. Ann Neurol 23(Suppl), 339–346 (1988)CrossRefGoogle Scholar
  3. 3.
    Levine AM, Gill PS, Meyer PR et al. Retrovirus and Malignant Lymphoma in Homosexual Men. JAMA 254, 1921–1925 (1985)PubMedCrossRefGoogle Scholar
  4. 4.
    Kaschka-Dierich C, Adams A, Lindahl T et al. Intracellular forms of Epstein-Barr virus DNA in human tumor cells in vivo. Nature 260, 302–6 (1976)PubMedCrossRefGoogle Scholar
  5. 5.
    Lindahl T, Adams A, Bjursell G et al. Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J Mol Biol 102, 511–530, (1976)PubMedCrossRefGoogle Scholar
  6. 6.
    Sugden B, Phelps M, Domoradzki J. Epstein-Barr virus DNA is amplified in transformed lymphocytes. J Virol 31, 590–595 (1979)PubMedGoogle Scholar
  7. 7.
    Klein G. Viral Latency and Transformation: The Strategy of Epstein-Barr Virus. Cell 58, 5–8 (1989)PubMedCrossRefGoogle Scholar
  8. 8.
    Cohen JI, Wang F, Mannick J et al. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci 86, 9558–9562 (1989)PubMedCrossRefGoogle Scholar
  9. 9.
    Kintner CR, Sugden B. Identification of cells transformed by Epstein-Barr-virus. Nature 294, 458–460 (1981)PubMedCrossRefGoogle Scholar
  10. 10.
    Sugden B, Metzenberg S. Characterization of an antigen whose cell surface expression is induced by infection with Epstein-Barr virus. J Virol 46, 800–807 (1983)PubMedGoogle Scholar
  11. 11.
    Rowe M, Rowe D.T., Gregory C.D. et al. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt’s lympoma cells. EMBO J 6, 2743–2751 (1987)PubMedGoogle Scholar
  12. 12.
    Azim T, Allday M.J., Crawford D.H. Immortalization of Epstein- Barr virus-infected CD23-negative B lymphocytes by the addition of B cell growth factor. J Gen Virol 71, 665–671 (1990)PubMedCrossRefGoogle Scholar
  13. 13.
    Mundinger F, Weigel K. Considerations in the usage and results of curietherapy. In: Modern Stereotactic Surgery, LD Lunsford (ed.). 245–263. Martinus Nijhoff Publishing, Boston, 1988Google Scholar
  14. 14.
    Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, New York 1982Google Scholar
  15. 15.
    Saiki RK, Gelfand DH, Stoffel S et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487–491 (1988)PubMedCrossRefGoogle Scholar
  16. 16.
    Rolfs A, Weigel K, Schumacher HC et al. Rapid detection of cytomegalovirus structures in cerebrospinal fluid and brain biopsies by polymerase chain reaction. New Engl J Med, submitted for publication (1990)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • Arndt Rolfs
  • Hermann Christian Schumacher
  • Martin Preuß
  • Ines Weber
  • Barbara Trampenau
  • Klaus Weigel
  • Theo Dissmann

There are no affiliations available

Personalised recommendations